Gilteritinib and the risk of intracranial hemorrhage: a case series of a possible, under-reported side effect. Perrone S, Imperatore S, Sucato G, Notarianni E, et al. Ann Hematol 2023;102:3025-3030.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Perrone S, Imperatore S, Sucato G, Notarianni E, et al. Gilteritinib and the risk of intracranial hemorrhage: a case series of a possible, under-reported side effect. Ann Hematol 2023;102:3025-3030.
PMID: 37606693